Acrobat Trial Group

Acrobat Trial Group (ATG) is a clinical research site network and site management organization (SMO) that specializes in the execution of Phase 1 through Phase 4 clinical trials. The company operates a network of high-performing research sites, primarily in Florida, providing pharmaceutical and biotechnology sponsors with streamlined access to diverse patient populations and high-quality data. ATG focuses on therapeutic areas such as cardiology, endocrinology, and infectious diseases, utilizing a centralized management model to optimize recruitment and regulatory compliance. In July 2022, Acrobat Trial Group was acquired by Velocity Clinical Research, a leading global clinical site organization, to enhance its site management capabilities and expand its geographic footprint. The group is recognized for its expertise in complex trial protocols and its ability to deliver rapid enrollment for large-scale clinical programs.